EUVIMEDOpdag EUVIMED
Multizentrische Studie

Vascular Access‐Site Complications in Chronic Total Occlusion Percutaneous Coronary Intervention

Michaella Alexandrou iD, Dimitrios Strepkos iD, Pedro E P Carvalho, Deniz Mutlu iD, Ozgur Selim Ser, Khaldoon Alaswad, Mir B Basir iD, Dmitrii Khelimskii iD, Oleg Krestyaninov, Jaikirshan J Khatri iD, Laura Young iD, Omer Goktekin and 15 more

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31501 ↗

At a glance

Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2025. Written by Michaella Alexandrou and 26 co-authors. Institution: Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Major MEDLINE topics: Percutaneous Coronary Intervention, Coronary Occlusion, Femoral Artery, Catheterization, Peripheral. Cited 1 times so far (Crossref); 43 references. Funded by: The authors are grateful for the philanthropic support of our generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A Sens; Mrs.….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Vascular access‐site complications (VASC) can occur during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

Methods

We compared the baseline and procedural characteristics, and outcomes of patients with versus without VASC in a large multicenter CTO PCI registry. VASC was defined as any of the following: small hematoma (hematoma < 5 cm), large hematoma (hematoma ≥ 5 cm), arteriovenous fistula, pseudoaneurysm and acute arterial closure.

Results

VASC occurred in 158 of 16,810 CTO PCIs (0.9%). VASC patients were older (67 ± 11 vs. 64 ± 10 years, p < 0.001), more likely to be women (28.4% vs. 19.1%, p = 0.004) and less likely to be current smokers (18.9% vs. 27.2%, p = 0.026). They were more likely to have at least one femoral access (89.2% vs. 75.3%, p < 0.001) and less likely to have any radial access (38.0% vs. 52.3%, p < 0.001). Transfemoral access was more common in patients with VASC (60.1% vs. 45.7%, p < 0.001). VASC cases had higher J‐CTO (2.57 vs. 2.38, p = 0.05) and PROGRESS‐CTO major adverse cardiac events (MACE) scores (3.27 vs. 2.58, p < 0.001). They had similar technical (87.3% vs. 87.1%, p > 0.9) and procedural (82.3% vs. 85.9%, p = 0.2) success, but higher MACE (6.3% vs. 1.9%, p < 0.001) and bleeding (23.4% vs. 0.4%, p < 0.001). Female gender (odds ratio [OR] 1.95, 95% confidence intervals [CI] 1.24−3.00, p = 0.003), at least one femoral access (OR 2.02, 95% CI 1.09‐4.04, p = 0.034) and sheath size (7‐F: OR 2.16, 95% CI 1.12−4.60, p = 0.031; 8‐F: OR 2.11, 95% CI 1.03−4.70, p = 0.051) were associated with VASC in multivariable analysis.

Conclusion

Female sex, femoral access and larger sheaths ≥ 7 F were associated with VASC in patients undergoing CTO PCI.

Subjects

MeSH terms (MEDLINE)

Percutaneous Coronary InterventionCoronary OcclusionFemoral ArteryCatheterization, PeripheralHumansFemaleAgedMaleRegistriesMiddle AgedChronic DiseaseRisk FactorsTreatment OutcomePuncturesHematomaRadial ArteryAneurysm, FalseOdds RatioTime FactorsArteriovenous Fistula

Author keywords

bleedingchronic total occlusionpercutaneous coronary interventionvascular access‐site complications

Authors and institutions

  • Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Henry Ford Cardiovascular Division, Detroit, Michigan, USA.
  • Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.
  • Cleveland Clinic, Cleveland, Ohio, USA.
  • Memorial Bahcelievler Hospital, Istanbul, Turkey.
  • University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

ORCID profiles: Michaella Alexandrou, Dimitrios Strepkos, Deniz Mutlu, Mir B Basir, Dmitrii Khelimskii, Jaikirshan J Khatri, Laura Young, Farouc A Jaffer, Sevket Gorgulu, Lorenzo Azzalini, Mahmut Uluganyan, Olga Mastrodemos, Sandeep Jalli, Yader Sandoval, Emmanouil S Brilakis

Funding

  • The authors are grateful for the philanthropic support of our generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A Sens; Mrs.…

Cite

APA

Alexandrou, M., Strepkos, D., Carvalho, P. E. P., Mutlu, D., Ser, O. S., Alaswad, K., Basir, M. B., Khelimskii, D., Krestyaninov, O., Khatri, J. J., Young, L., Goktekin, O., Poommipanit, P., Jaffer, F. A., Gorgulu, S., Azzalini, L., Ozdemir, R., Uluganyan, M., Raj, L. M., …, & Brilakis, E. S. (2025). Vascular Access‐Site Complications in Chronic Total Occlusion Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31501

Vancouver

Alexandrou M, Strepkos D, Carvalho PEP, Mutlu D, Ser OS, Alaswad K, et al. Vascular Access‐Site Complications in Chronic Total Occlusion Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31501

BibTeX
@article{Alexandrou2025,
  author = {Alexandrou, Michaella and Strepkos, Dimitrios and Carvalho, Pedro E P and Mutlu, Deniz and Ser, Ozgur Selim and Alaswad, Khaldoon and Basir, Mir B and Khelimskii, Dmitrii and Krestyaninov, Oleg and Khatri, Jaikirshan J and Young, Laura and Goktekin, Omer and Poommipanit, Paul and Jaffer, Farouc A and Gorgulu, Sevket and Azzalini, Lorenzo and Ozdemir, Ramazan and Uluganyan, Mahmut and Raj, Leah M and Mastrodemos, Olga and Sara, Jaskanwal Deep S and Rangan, Bavana V and Jalli, Sandeep and Voudris, Konstantinos V and Sandoval, Yader and Burke, M Nicholas and Brilakis, Emmanouil S},
  title = {Vascular Access‐Site Complications in Chronic Total Occlusion Percutaneous Coronary Intervention},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31501}
}
Start for free →